Complementary and Alternative Medicine Use, Patient-reported Outcomes, and Treatment Satisfaction Among Men With Localized Prostate Cancer

被引:7
作者
Ramsey, Scott D. [1 ]
Zeliadt, Steven B.
Blough, David K.
Fedorenko, Catherine R.
Fairweather, Megan E.
McDermott, Cara L.
Penson, David F.
Van Den Eeden, Stephen K.
Hamilton, Ann S.
Arora, Neeraj K.
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
关键词
QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; PREVALENCE; THERAPY; CAPSURE; BOTHER;
D O I
10.1016/j.urology.2012.01.023
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To evaluate the association between complementary and alternative medicine (CAM) use, satisfaction with treatment, and patient-reported outcomes after treatment. METHODS The Prostate CAncer Therapy Selection Study prospectively surveyed patients newly diagnosed with localized prostate cancer about their treatment decision-making process and outcomes. The Prostate CAncer Therapy Selection Study recruited patients from 3 geographic areas through hospital-based urology clinics and community urology practices. RESULTS More than 700 patients completed the baseline and follow-up surveys. More than 50% of respondents reported using CAM; this decreased to 39% if prayer was excluded as a type of CAM. On multivariate analysis, factors related to communication with the treating physician, but not CAM use, were associated with treatment satisfaction. The likelihood of stability or improvement in urinary, bowel, and sexual function at 6 months was related to the choice of primary therapy but was unrelated to CAM use. CONCLUSION In the present prospective observational study, CAM use was highly prevalent but unrelated to treatment satisfaction or changes in functional status. The effect of CAM on these endpoints remains to be established in comparative effectiveness studies. UROLOGY 79: 1034-1041, 2012. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1034 / 1041
页数:8
相关论文
共 30 条
[1]  
[Anonymous], 2011, SEER CANC STAT REV
[2]   Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies [J].
Bishop, F. L. ;
Rea, A. ;
Lewith, H. ;
Chan, Y. K. ;
Saville, J. ;
Prescott, P. ;
von Elm, E. ;
Lewith, G. T. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2011, 14 (01) :1-13
[3]   Use of complementary/alternative medicine by men diagnosed with prostate cancer: Prevalence and characteristics [J].
Boon, H ;
Westlake, K ;
Stewart, M ;
Gray, R ;
Fleshner, N ;
Gavin, A ;
Brown, JB ;
Goel, V .
UROLOGY, 2003, 62 (05) :849-853
[4]   Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer [J].
D'Amico, Anthony V. ;
Hui-Chen, Ming ;
Renshaw, Andrew A. ;
Sussman, Brenda ;
Roehl, Kimberly A. ;
Catalona, William J. .
JOURNAL OF UROLOGY, 2006, 176 (06) :S11-S15
[5]   Perceptions about complementary therapies relative to conventional therapies among adults who use both: Results from a national survey [J].
Eisenberg, DM ;
Kessler, RC ;
Van Rompay, MI ;
Kaptchuk, TJ ;
Wilkey, SA ;
Appel, S ;
Davis, RB .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (05) :344-351
[6]  
Eng Joanna, 2003, Integr Cancer Ther, V2, P212, DOI 10.1177/1534735403256207
[7]   Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study [J].
Hall, JD ;
Bissonette, EA ;
Boyd, JC ;
Theodorescu, D .
BJU INTERNATIONAL, 2003, 91 (07) :603-607
[8]   Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument [J].
Hollenbeck, BK ;
Dunn, RL ;
Wei, JT ;
Montie, JE ;
Sanda, MG .
JOURNAL OF UROLOGY, 2003, 169 (04) :1453-1457
[9]  
Kao GD, 2000, CANCER, V88, P615, DOI 10.1002/(SICI)1097-0142(20000201)88:3<615::AID-CNCR18>3.0.CO
[10]  
2-P